J&J, after surprisingly strong 2Q, ups outlook for the year
Johnson & Johnson beat Wall Street’s second-quarter expectations and bumped up its 2020 forecast even though COVID-19 contributed to a 40% drop in U.S. medical device sales By TOM MURPHY … Read More
![]()

